Early-stage life sciences investing
Turning complexity into conviction.
ChaosBio is an early-stage life sciences investment platform backing founders across therapeutics, medical devices, digital health, and the technologies shaping the future of drug development and biomanufacturing.
ChaosBio Intelligence is the research and intelligence platform behind our investment decisions, bringing together scientific, clinical, competitive, and market insights to turn complexity into conviction.
The intelligence framework
Research
Scientific, clinical, competitive and market intelligence, drawn from trial registries, the published literature, regulatory records, patents and financial filings.
Diligence
Structured evaluation of early-stage life sciences opportunities, assembled from that evidence rather than from narrative.
Monitoring
Ongoing tracking of companies, technologies, markets and the developments that change a thesis after it is written.
Where ChaosBio invests
- Therapeutics
- Medical devices
- Digital health
- Life sciences infrastructure
ChaosBio Intelligence supports ChaosBio’s investment activity. Company research, diligence and portfolio monitoring are private and available to the ChaosBio team.